{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:03:33Z","timestamp":1784937813230,"version":"3.55.0"},"reference-count":314,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jaut.2019.102328","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:45:20Z","timestamp":1568965520000},"page":"102328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["The challenges of primary biliary cholangitis: What is new and what needs to be done"],"prefix":"10.1016","volume":"105","author":[{"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Alpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chazouill\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Krawitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Mavilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon MM.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Strazzabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Zigmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jaut.2019.102328_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2018","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.jaut.2019.102328_bib4","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102328_bib5","first-page":"267","article-title":"On a certain affection of the skin, Vitiligoidea:(a) Plana,(b) Tuberosa","volume":"7","author":"Addison","year":"1851","journal-title":"Guy\u2019s Hosp. Rep."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib6","first-page":"1","article-title":"Primary biliary cirrhosis","volume":"61","author":"Dauphinee","year":"1949","journal-title":"Can. Med. Assoc. J."},{"issue":"6 Pt 2","key":"10.1016\/j.jaut.2019.102328_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI102222","article-title":"The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis","volume":"28","author":"Ahrens","year":"1949","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM195801232580407","article-title":"Primary biliary cirrhosis showing a high titer of autoantibody; report of a case","volume":"258","author":"Mackay","year":"1958","journal-title":"N. Engl. J. Med."},{"issue":"7390","key":"10.1016\/j.jaut.2019.102328_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"62","author":"Beuers","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib11","first-page":"3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol Baltim Md"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib13","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","article-title":"The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study","volume":"24","author":"Baldursdottir","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","article-title":"Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England","volume":"26","author":"Metcalf","year":"1997","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","article-title":"Population-based epidemiology of primary biliary cirrhosis in South Korea","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9039","key":"10.1016\/j.jaut.2019.102328_bib18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaut.2017.07.003","article-title":"Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review","volume":"83","author":"Ma","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2019.04.004","article-title":"Florid biliary duct lesions in an AMA -positive patient in absence of cholestatic liver biochemistry","volume":"101","author":"Sultan","year":"2019","journal-title":"J. Autoimmun."},{"issue":"22","key":"10.1016\/j.jaut.2019.102328_bib24","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2468-1253(19)30094-9","article-title":"Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study","volume":"4","author":"Trauner","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cgh.2017.12.017","article-title":"Increased waitlist mortality and lower rate for liver transplantation in hispanic patients with primary biliary cholangitis","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib28","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","article-title":"Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history","volume":"67","author":"Murillo Perez","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib30","article-title":"The contribution of B cells in autoimmune liver diseases","author":"Taylor","year":"2019","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/CS20181123","article-title":"Immunological abnormalities in patients with primary biliary cholangitis","volume":"133","author":"Ma","year":"2019","journal-title":"Clin Sci Lond Engl"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol. Int."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2559.2006.02537.x","article-title":"Proposal of a new staging and grading system of the liver for primary biliary cirrhosis","volume":"49","author":"Hiramatsu","year":"2006","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","article-title":"Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score","volume":"3","author":"Carbone","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib37","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102328_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J. Autoimmun."},{"issue":"7669","key":"10.1016\/j.jaut.2019.102328_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature23670","article-title":"Public antibodies to malaria antigens generated by two LAIR1 insertion modalities","volume":"548","author":"Pieper","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102328_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","article-title":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: a comprehensive overview","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib41","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1515\/cclm-2017-1152","article-title":"Reference standards for the detection of anti-mitochondrial and anti-rods\/rings autoantibodies","volume":"56","author":"Calise","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.humimm.2019.02.012","article-title":"Prevalence of autoimmune diseases and clinical significance of autoantibody profile: data from National Institute of Hygiene in Rabat, Morocco","volume":"80","author":"Missoum","year":"2019","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib43","first-page":"237","article-title":"Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications","volume":"1","author":"Doniach","year":"1966","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib44","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/00365520310004876","article-title":"Clinical significance of anti-multiple nuclear dots\/Sp100 autoantibodies","volume":"38","author":"Wichmann","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0034-1383732","article-title":"Clinical significance of autoantibodies in primary biliary cirrhosis","volume":"34","author":"Nakamura","year":"2014","journal-title":"Semin. Liver Dis."},{"issue":"15\u201316","key":"10.1016\/j.jaut.2019.102328_bib46","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin. Chim."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib47","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"12","key":"10.1016\/j.jaut.2019.102328_bib51","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaut.2005.10.007","article-title":"Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis","volume":"26","author":"Nakamura","year":"2006","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2012.04577.x","article-title":"Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent","volume":"168","author":"Yang","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.102328_bib54","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/S0168-8278(09)60678-4","article-title":"676 fine specificity of anti-NUP62 T-helper 1 cell (TH1) immune response in primary biliary cirrhosis","volume":"50","author":"Meda","year":"2009","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib55","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/gut.47.4.586","article-title":"PBC: an infectious disease?","volume":"47","author":"HAYDON","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2019.102328_bib56","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat. Commun."},{"issue":"6005","key":"10.1016\/j.jaut.2019.102328_bib57","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"issue":"6077","key":"10.1016\/j.jaut.2019.102328_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.1219179","article-title":"A lineage of myeloid cells independent of Myb and hematopoietic stem cells","volume":"336","author":"Schulz","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.23318","article-title":"CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis","volume":"51","author":"Shimoda","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10620-013-2920-6","article-title":"Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis","volume":"59","author":"Sasaki","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib62","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.20859","article-title":"Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis","volume":"42","author":"Mao","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ni1309","article-title":"Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2","volume":"7","author":"Serbina","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2019.102328_bib64","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3389\/fimmu.2018.01852","article-title":"The critical role of chemokine (C-C motif) receptor 2-positive monocytes in autoimmune cholangitis","volume":"9","author":"Reuveni","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib65","first-page":"1128","article-title":"Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents","volume":"38","author":"Yu","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib66","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"issue":"6617","key":"10.1016\/j.jaut.2019.102328_bib68","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.20582","article-title":"Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts","volume":"41","author":"Isse","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2011.05.009","article-title":"T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1","volume":"37","author":"Zhang","year":"2011","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib71","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s10620-013-2734-6","article-title":"Clinicopathological significance of serum fractalkine in primary biliary cirrhosis","volume":"58","author":"Harada","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"5904","key":"10.1016\/j.jaut.2019.102328_bib72","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib73","first-page":"3426","article-title":"Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes","volume":"185","author":"Kamphorst","year":"2010","journal-title":"J Immunol Baltim Md"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2011.08.008","article-title":"CD8\u03b1(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites","volume":"35","author":"Mashayekhi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.102328_bib75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","article-title":"The role of natural killer cells in autoimmune liver disease: a comprehensive review","volume":"46","author":"Hudspeth","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","article-title":"Human liver-resident CD56(bright)\/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways","volume":"66","author":"Hudspeth","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib78","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"An organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib79","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.24194","article-title":"Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis","volume":"53","author":"Shimoda","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib80","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib81","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.22102","article-title":"Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells","volume":"47","author":"Shimoda","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaut.2016.08.006","article-title":"Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis","volume":"75","author":"Hisamoto","year":"2016","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib83","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis","volume":"102","author":"Shimoda","year":"1998","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.20494","article-title":"Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases","volume":"41","author":"Kamihira","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2006.05.056","article-title":"Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory","volume":"131","author":"Shimoda","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib86","first-page":"3315","article-title":"Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis","volume":"179","author":"Kawano","year":"2007","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.jaut.2019.102328_bib87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpg.2018.05.012","article-title":"Pathophysiology of primary biliary cholangitis","volume":"34\u201335","author":"Gulamhusein","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib88","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41467-019-09893-5","article-title":"Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines","volume":"10","author":"Umeshappa","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2019.102328_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaut.2018.09.009","article-title":"Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis","volume":"95","author":"Hsueh","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.10.015","article-title":"The immunobiology of female predominance in primary biliary cholangitis","volume":"95","author":"Gerussi","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2017.12.011","article-title":"CD8+ T cells and IFN-\u03b3 induce autoimmune myelofibrosis in mice","volume":"89","author":"Yao","year":"2018","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib92","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep4.1226","article-title":"Follicular T helper cell signatures in primary biliary cholangitis and primary sclerosing cholangitis","volume":"2","author":"Adam","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jaut.2019.102328_bib93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-\u03b3 secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib94","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12072-018-9882-x","article-title":"Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells","volume":"12","author":"Atif","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jaut.2019.102328_bib95","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2018.01.007","article-title":"The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: regulation by cholic acid-induced Interleukin-7","volume":"90","author":"Jiang","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaut.2016.12.012","article-title":"Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation","volume":"78","author":"Ma","year":"2017","journal-title":"J. Autoimmun."},{"issue":"19","key":"10.1016\/j.jaut.2019.102328_bib97","doi-asserted-by":"crossref","first-page":"26992","DOI":"10.18632\/oncotarget.8853","article-title":"Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib98","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.ajpath.2010.12.039","article-title":"Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans","volume":"178","author":"Link","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib99","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0002-9440(10)62570-9","article-title":"Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease","volume":"160","author":"Grant","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib100","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib101","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2015.12.017","article-title":"Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1","volume":"64","author":"Jeffery","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib102","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0002-9440(10)61116-9","article-title":"Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects","volume":"160","author":"Nijjar","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib103","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.28517","article-title":"Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib104","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2016.00477","article-title":"Stromal fibroblasts in tertiary lymphoid structures: a novel target in chronic inflammation","volume":"7","author":"Barone","year":"2016","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ni.1905","article-title":"Epithelial decision makers: in search of the \u2018epimmunome\u2019","volume":"11","author":"Swamy","year":"2010","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib106","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2019.102328_bib108","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fendo.2017.00343","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib109","first-page":"2309","article-title":"MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo","volume":"175","author":"Kupfer","year":"2005","journal-title":"J Immunol Baltim Md"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib110","first-page":"1504","article-title":"Simultaneous recognition of allogeneic MHC and cognate autoantigen by autoreactive T cells in transplant rejection","volume":"200","author":"Burrack","year":"2018","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.jaut.2019.102328_bib111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032414-112056","article-title":"Heterogeneity of human CD4(+) T cells against microbes","volume":"34","author":"Sallusto","year":"2016","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib112","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.coi.2004.09.012","article-title":"Chemoattractants and their receptors in homeostasis and inflammation","volume":"16","author":"Sallusto","year":"2004","journal-title":"Curr. Opin. Immunol."},{"issue":"1 Suppl","key":"10.1016\/j.jaut.2019.102328_bib113","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib114","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jhep.2018.08.020","article-title":"Primary biliary cholangitis: a tale of epigenetically-induced secretory failure?","volume":"69","author":"Rodrigues","year":"2018","journal-title":"J. Hepatol."},{"issue":"10139","key":"10.1016\/j.jaut.2019.102328_bib115","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib116","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib117","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.21042","article-title":"Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger","volume":"43","author":"Banales","year":"2006","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib118","first-page":"10269","article-title":"Secretin\/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis","volume":"33","author":"Kennedy","year":"2019","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","article-title":"Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis","volume":"25","author":"Medina","year":"1997","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib120","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","article-title":"Defective regulation of cholangiocyte Cl-\/HCO3(-) and Na+\/H+ exchanger activities in primary biliary cirrhosis","volume":"35","author":"Melero","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib122","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"Arenas","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib123","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2019.102328_bib124","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: a comprehensive review","volume":"99","author":"Amaya-Uribe","year":"2019","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/1751-2980.12790","article-title":"Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency","volume":"20","author":"Ronca","year":"2019","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jaut.2019.102328_bib126","series-title":"Physiology of Membrane Disorders [Internet]","first-page":"609","article-title":"Mechanisms of bile secretion and hepatic transport","author":"Boyer","year":"1986"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib127","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J. Hepatol."},{"issue":"3\u20134","key":"10.1016\/j.jaut.2019.102328_bib130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","article-title":"Primary biliary cirrhosis is associated with altered hepatic microRNA expression","volume":"32","author":"Padgett","year":"2009","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2012.02.060","article-title":"Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma","volume":"419","author":"Zhai","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib132","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4 Pt B","key":"10.1016\/j.jaut.2019.102328_bib133","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2017.09.022","article-title":"Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis","volume":"1864","author":"Chang","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib134","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000371864","article-title":"The cholangiocyte glycocalyx stabilizes the \u2018biliary HCO3 umbrella\u2019: an integrated line of defense against toxic bile acids","volume":"33","author":"Maillette de Buy Wenniger","year":"2015","journal-title":"Dig Dis Basel Switz"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib136","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib137","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib138","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcmgh.2019.04.013","article-title":"Pathophysiology of cystic fibrosis liver disease: a channelopathy leading to alterations in innate immunity and in microbiota","volume":"8","author":"Fiorotto","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib139","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-\u03baB-mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib140","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep.29400","article-title":"Src kinase inhibition reduces inflammatory and cytoskeletal changes in \u0394F508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy","volume":"67","author":"Fiorotto","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib141","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0046-8177(97)90151-9","article-title":"Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis","volume":"28","author":"Washington","year":"1997","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib142","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jhep.2016.02.003","article-title":"Lights on MAIT cells, a new immune player in liver diseases","volume":"64","author":"Toubal","year":"2016","journal-title":"J. Hepatol."},{"issue":"7500","key":"10.1016\/j.jaut.2019.102328_bib143","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature13160","article-title":"T-cell activation by transitory neo-antigens derived from distinct microbial pathways","volume":"509","author":"Corbett","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib144","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/jgh.14076","article-title":"Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis","volume":"33","author":"Setsu","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib145","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep.21143","article-title":"Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases","volume":"43","author":"Fabris","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib146","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/hep.29652","article-title":"\u03b2-Catenin and interleukin-1\u03b2-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis","volume":"67","author":"Kaffe","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib147","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2019.102328_bib148","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2015.00597","article-title":"Macrophage and innate lymphoid cell interplay in the genesis of fibrosis","volume":"6","author":"Hams","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib149","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.molcel.2014.03.030","article-title":"Stress, inflammation, and defense of homeostasis","volume":"54","author":"Chovatiya","year":"2014","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib150","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2009.12.022","article-title":"Foxa1 and Foxa2 regulate bile duct development in mice","volume":"52","author":"Strazzabosco","year":"2010","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib151","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jhep.2011.09.022","article-title":"Development of the bile ducts: essentials for the clinical hepatologist","volume":"56","author":"Strazzabosco","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib152","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/hep.27268","article-title":"Emerging roles of Notch signaling in liver disease","volume":"61","author":"Geisler","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib153","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/jaut.2001.0522","article-title":"Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis","volume":"17","author":"Tanaka","year":"2001","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib154","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajpath.2017.11.010","article-title":"Hepatic stem\/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis","volume":"188","author":"Carpino","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib155","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbadis.2018.08.038","article-title":"Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases","volume":"1865","author":"Fiorotto","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib156","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib157","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","author":"\u00d6rnolfsson","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib158","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cld.2018.03.002","article-title":"The genetics and epigenetics of primary biliary cholangitis","volume":"22","author":"Tanaka","year":"2018","journal-title":"Clin. Liver Dis."},{"issue":"24","key":"10.1016\/j.jaut.2019.102328_bib159","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.jaut.2019.102328_bib160","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1093\/hmg\/dds359","article-title":"Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants","volume":"21","author":"Juran","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib161","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2019.102328_bib162","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1038\/ncomms14828","article-title":"A genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib163","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clinre.2015.05.002","article-title":"Making the most of new genetic risk factors - genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"39","author":"Mells","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib164","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib165","first-page":"2145","article-title":"Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis","volume":"197","author":"Gil-Farina","year":"2016","journal-title":"J Immunol Baltim Md"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib166","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.28641","article-title":"Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance","volume":"64","author":"Bae","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib167","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib168","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","article-title":"An expanded view of complex traits: from polygenic to omnigenic","volume":"169","author":"Boyle","year":"2017","journal-title":"Cell"},{"issue":"7410","key":"10.1016\/j.jaut.2019.102328_bib169","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature11319","article-title":"Gut microbiota composition correlates with diet and health in the elderly","volume":"488","author":"Claesson","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib170","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cmet.2015.10.001","article-title":"Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella","volume":"22","author":"Kovatcheva-Datchary","year":"2015","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib171","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota","volume":"1","author":"Jernberg","year":"2007","journal-title":"ISME J."},{"issue":"7413","key":"10.1016\/j.jaut.2019.102328_bib172","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nature11400","article-title":"Antibiotics in early life alter the murine colonic microbiome and adiposity","volume":"488","author":"Cho","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102328_bib173","first-page":"1","article-title":"Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome","author":"Fodor","year":"2018","journal-title":"Gut Microb."},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib174","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1038\/ctg.2016.44","article-title":"Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition","volume":"7","author":"Kang","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162983","article-title":"Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp. longum 35624TM","volume":"11","author":"Altmann","year":"2016","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.jaut.2019.102328_bib176","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1128\/AEM.02238-16","article-title":"The surface-associated exopolysaccharide of Bifidobacterium longum 35624 plays an essential role in dampening host proinflammatory responses and repressing local TH17 responses","volume":"82","author":"Schiavi","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib177","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/gutjnl-2011-300936","article-title":"Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells","volume":"61","author":"Konieczna","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib178","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microb."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib179","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib180","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/19490976.2017.1361092","article-title":"Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection","volume":"9","author":"Sokol","year":"2018","journal-title":"Gut Microb."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib182","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40168-017-0269-3","article-title":"Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease","volume":"5","author":"Khanna","year":"2017","journal-title":"Microbiome"},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib183","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib184","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","article-title":"Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan","volume":"57","author":"Harada","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib185","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib186","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27306","article-title":"CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib187","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.27725","article-title":"Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis","volume":"61","author":"Li","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib188","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"issue":"24","key":"10.1016\/j.jaut.2019.102328_bib189","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut-liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"6380","key":"10.1016\/j.jaut.2019.102328_bib191","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"issue":"6380","key":"10.1016\/j.jaut.2019.102328_bib192","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.aat0835","article-title":"Intestinal barriers protect against disease","volume":"359","author":"Citi","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib193","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","article-title":"Nuclear receptors as therapeutic targets in cholestatic liver diseases","volume":"156","author":"Zollner","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib194","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib195","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.102328_bib196","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","author":"Chen","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib197","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep.28718","article-title":"Mouse model of primary biliary cholangitis with a striking female predominance: a new powerful research tool","volume":"64","author":"Vergani","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib198","first-page":"930","article-title":"Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans","volume":"14","author":"Tanaka","year":"2018","journal-title":"Arch Med Sci AMS"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib199","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep4.1044","article-title":"Toward solving the etiological mystery of primary biliary cholangitis","volume":"1","author":"Tanaka","year":"2017","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib200","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis","volume":"203","author":"Irie","year":"2006","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib201","first-page":"1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol Baltim Md"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib202","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/cei.12806","article-title":"Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice","volume":"185","author":"Yang","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib203","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cei.12581","article-title":"Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis","volume":"180","author":"Tanaka","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.12415","article-title":"Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells","volume":"178","author":"Tanaka","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cei.12193","article-title":"Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis","volume":"174","author":"Tanaka","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib206","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.26418","article-title":"Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGF\u03b2RII mice","volume":"58","author":"Kawata","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib207","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2012.12.013","article-title":"Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-\u03b2 receptor type II mouse","volume":"41","author":"Ando","year":"2013","journal-title":"J. Autoimmun."},{"issue":"11","key":"10.1016\/j.jaut.2019.102328_bib208","article-title":"Lymphoma-like T cell infiltration in liver is associated with increased copy number of dominant negative form of TGF\u03b2 receptor II","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib209","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.25829","article-title":"Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGF\u03b2 receptor type II mice","volume":"57","author":"Tsuda","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib210","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.25803","article-title":"The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice","volume":"56","author":"Ando","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib211","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.23664","article-title":"Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis","volume":"52","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib212","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","volume":"50","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib213","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib214","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.2009.03971.x","article-title":"Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis","volume":"157","author":"Zhang","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib215","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/j.gastro.2008.11.035","article-title":"B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis","volume":"136","author":"Moritoki","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2019.102328_bib216","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-019-0227-z","article-title":"IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sj\u00f6gren's syndrome","author":"Lin","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib217","first-page":"7221","article-title":"CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice","volume":"181","author":"Wei","year":"2008","journal-title":"J Immunol Baltim Md"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib218","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/hep.22226","article-title":"Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice","volume":"47","author":"Yang","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib219","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib220","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(-\/-) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib221","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.22591","article-title":"Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-\/-) mice","volume":"49","author":"Hsu","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib222","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib223","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","article-title":"Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2R\u03b1(-\/-) mice","volume":"51","author":"Yao","year":"2014","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105351","article-title":"Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2R\u03b1 deleted mice","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib225","doi-asserted-by":"crossref","first-page":"e2439","DOI":"10.1038\/cddis.2016.348","article-title":"Block of both TGF-\u03b2 and IL-2 signaling impedes Neurophilin-1+ regulatory T cell and follicular regulatory T cell development","volume":"7","author":"Li","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2019.102328_bib226","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3389\/fimmu.2018.01090","article-title":"The CXC chemokine receptor 3 inhibits autoimmune cholangitis via\u2009CD8+ T cells but promotes Colitis\u2009via CD4+ T cells","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib227","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.22651","article-title":"Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis","volume":"49","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"issue":"2\u20133","key":"10.1016\/j.jaut.2019.102328_bib228","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12016-015-8482-y","article-title":"Animal models of primary biliary cirrhosis","volume":"48","author":"Katsumi","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib229","first-page":"2651","article-title":"Induction of primary biliary cirrhosis in Guinea pigs following chemical xenobiotic immunization","volume":"179","author":"Leung","year":"2007","journal-title":"J Immunol Baltim Md"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib230","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib231","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2004.11.005","article-title":"Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis","volume":"128","author":"Kikuchi","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib232","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/hep.21522","article-title":"AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers","volume":"45","author":"Moritoki","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib233","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","article-title":"The \u2018short\u2019 history of regulatory B cells","volume":"29","author":"Mauri","year":"2008","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2019.102328_bib234","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1038\/ctg.2017.34","article-title":"Primary biliary cholangitis alters functional connections of the brain's deep gray matter","volume":"8","author":"Mosher","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib235","first-page":"6","article-title":"Fatigue in chronic liver disease: new insights and therapeutic approaches","volume":"39","author":"Swain","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib236","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European association for the study of the liver. EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib237","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000444472","article-title":"Variant syndromes of autoimmune liver diseases: classification, diagnosis and management","volume":"34","author":"Weiler-Normann","year":"2016","journal-title":"Dig Dis Basel Switz"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib238","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J. Hepatol."},{"issue":"16","key":"10.1016\/j.jaut.2019.102328_bib239","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-2001-12906","article-title":"[Presence of SLA\/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)]","volume":"126","author":"Kanzler","year":"2001","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u2018overlap\u2019 syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib241","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib242","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2019.102328_bib243","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","article-title":"Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis","volume":"41","author":"Wang","year":"2013","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib244","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib246","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib247","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","article-title":"Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis","volume":"12","author":"Ozaslan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib248","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12016-017-8649-9","article-title":"Skin manifestations associated with autoimmune liver diseases: a systematic review","volume":"53","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102328_bib249","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.05.008","article-title":"Evolution of our understanding of PBC","volume":"34\u201335","author":"Tanaka","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib250","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib251","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu. Rev. Pathol."},{"issue":"9777","key":"10.1016\/j.jaut.2019.102328_bib252","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib253","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib254","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib256","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib257","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1155\/2010\/752314","article-title":"Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis","volume":"29","author":"Selmi","year":"2010","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jaut.2019.102328_bib258","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J. Autoimmun."},{"issue":"9894","key":"10.1016\/j.jaut.2019.102328_bib259","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib260","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","article-title":"Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium","volume":"136","author":"D'Aldebert","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib261","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.24597","article-title":"Seasonal variation in the patient diagnosis of primary biliary cirrhosis: further evidence for an environmental component to etiology","volume":"54","author":"McNally","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib262","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejim.2017.05.006","article-title":"Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece","volume":"42","author":"Gatselis","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2019.102328_bib263","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bpg.2018.06.001","article-title":"Is PBC a viral infectious disease?","volume":"34\u201335","author":"Mason","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib264","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3748\/wjg.v22.i1.349","article-title":"Combination antiretroviral studies for patients with primary biliary cirrhosis","volume":"22","author":"Lytvyak","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.jaut.2019.102328_bib265","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/j.1572-0241.2004.40741.x","article-title":"Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis","volume":"99","author":"Mason","year":"2004","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib266","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","article-title":"Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib267","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2016.03.019","article-title":"Autotaxin, pruritus and primary biliary cholangitis (PBC)","volume":"15","author":"Sun","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib268","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211906","article-title":"Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions","volume":"14","author":"Mosher","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib269","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2010.05.026","article-title":"The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up","volume":"53","author":"Jones","year":"2010","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/gut.2003.016766","article-title":"Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels","volume":"53","author":"Forton","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190005","article-title":"Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure","volume":"13","author":"Zenouzi","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib272","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.22371","article-title":"Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology","volume":"48","author":"Newton","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib273","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41687-018-0090-1","article-title":"Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis","volume":"3","author":"Martin","year":"2019","journal-title":"J. Patient-Rep. Outcomes"},{"issue":"11","key":"10.1016\/j.jaut.2019.102328_bib274","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1136\/gut.2005.065862","article-title":"Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis","volume":"54","author":"Jacoby","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib276","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2019.102328_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jaut.2019.102328_bib278","article-title":"Clinical trials in PBC going forward","author":"Corpechot","year":"2019","journal-title":"Semin. Liver Dis."},{"issue":"11","key":"10.1016\/j.jaut.2019.102328_bib279","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","article-title":"Principles for modulation of the nuclear receptor superfamily","volume":"3","author":"Gronemeyer","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2009.12.002","article-title":"The new therapeutic frontier--nuclear receptors and the liver","volume":"52","author":"Karpen","year":"2010","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib281","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102328_bib282","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2014.02.010","article-title":"The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury","volume":"53","author":"Zhang","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102328_bib283","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib284","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(03)00228-9","article-title":"Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine","volume":"39","author":"Zollner","year":"2003","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib285","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.jaut.2019.102328_bib286","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib287","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2017.10.018","article-title":"Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems","volume":"16","author":"Lu","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102328_bib288","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment","volume":"16","author":"Lu","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib289","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10059-012-2297-y","article-title":"The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases","volume":"33","author":"Choi","year":"2012","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib290","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0036-1597929","article-title":"Novel treatment strategies for primary biliary cholangitis","volume":"37","author":"Par\u00e9s","year":"2017","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib291","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0000000000000056","article-title":"Fibrate treatment for primary biliary cirrhosis","volume":"30","author":"Cuperus","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib292","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/apt.13465","article-title":"Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes","volume":"43","author":"Cheung","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib293","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1665-2681(19)31500-5","article-title":"Budd-Chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis","volume":"11","author":"Mederacke","year":"2012","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib294","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis","volume":"38","author":"Hempfling","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib295","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib296","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib297","first-page":"1478","article-title":"Characterization and treatment of persistent hepatocellular secretory failure","volume":"35","author":"van Dijk","year":"2015","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jaut.2019.102328_bib298","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2015.03.020","article-title":"Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy","volume":"189","author":"Geenes","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102328_bib299","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.08.017","article-title":"Metabolic preconditioning protects BSEP\/ABCB11-\/- mice against cholestatic liver injury","volume":"66","author":"Fuchs","year":"2017","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102328_bib300","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1194\/jlr.M084145","article-title":"Thyroid hormone receptor \u03b21 stimulates ABCB4 to increase biliary phosphatidylcholine excretion in mice","volume":"59","author":"Gautherot","year":"2018","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib301","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.108.145987","article-title":"Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice","volume":"328","author":"Ogura","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib302","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib303","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Par\u00e9s","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jaut.2019.102328_bib304","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaut.2019.102328_bib305","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib306","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib307","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib308","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ajg.2013.51","article-title":"B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid","volume":"108","author":"Myers","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102328_bib309","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.24748","article-title":"Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"55","author":"Tsuda","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.102328_bib310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep4.1170","article-title":"NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid","volume":"2","author":"de Graaf","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jaut.2019.102328_bib311","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(18)30293-9","article-title":"GS-011 - results of a randomised controlled trial of budesonide add-on therapy in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid","volume":"68","author":"Hirschfield","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102328_bib312","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(19)40311-9","article-title":"Mo1470 \u2013 secretin\/secretin receptor signaling modulates biliary immunobiology and subsequent T cell migration in early stage primary biliary cholangitis (PBC)","volume":"156","author":"Kennedy","year":"2019","journal-title":"Gastroenterology"},{"issue":"4 Pt B","key":"10.1016\/j.jaut.2019.102328_bib313","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbadis.2017.06.017","article-title":"Mechanisms of cholangiocyte responses to injury","volume":"1864","author":"Sato","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"10","key":"10.1016\/j.jaut.2019.102328_bib314","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.ajpath.2018.06.015","article-title":"The secretin\/secretin receptor Axis modulates ductular reaction and liver fibrosis through changes in transforming growth factor-\u03b21-mediated biliary senescence","volume":"188","author":"Wu","year":"2018","journal-title":"Am. J. Pathol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:25:27Z","timestamp":1760257527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119304901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":314,"alternative-id":["S0896841119304901"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102328","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The challenges of primary biliary cholangitis: What is new and what needs to be done","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102328"}}